Date published: 2026-2-23

1-800-457-3801

SCBT Portrait Logo
Seach Input

DC-SIGN_CD209a Activators

DC-SIGN/CD209a Activators, in this context, refer to a group of chemical compounds that indirectly influence the functional activity of DC-SIGN/CD209a, a critical receptor on dendritic cells involved in pathogen recognition and antigen presentation. Compounds like Chloroquine and Ammonium Chloride, known for their roles in modulating endosomal pH, could enhance DC-SIGN/CD209a activity by affecting the receptor's ligand-binding ability and antigen processing mechanisms. Similarly, Monodansylcadaverine and Dynasore, which impact lysosomal activity and endocytic trafficking respectively, may augment the receptor's role in antigen presentation by altering intracellular trafficking routes. Chemicals that influence cellular membranes and cytoskeletal arrangements, such as Methyl-β-cyclodextrin, Filipin III, and Cytochalasin D, can also have indirect effects on DC-SIGN/CD209a activity. By altering membrane microdomains or disrupting lipid rafts, these compounds can affect receptor localization and function, potentially enhancing the receptor's ability to mediate endocytosis and subsequent antigen presentation.

Calcium channel blockers like Nicardipine, and microtubule-affecting agents such as Colchicine, may further modulate DC-SIGN/CD209a activity by influencing calcium-dependent processes and microtubule dynamics, crucial for dendritic cell function. Moreover, inhibitors of key signaling pathways, such as Wortmannin (a PI3K inhibitor) and Genistein (a tyrosine kinase inhibitor), could indirectly enhance DC-SIGN/CD209a function by modulating cellular signaling. This modulation can impact the maturation of dendritic cells and their capacity for antigen uptake and presentation. Nystatin, with its role in altering membrane cholesterol content, may also influence DC-SIGN/CD209a distribution and function, further impacting the receptor's immunological role. Collectively, these compounds, through their various mechanisms, facilitate the enhancement of DC-SIGN/CD209a-mediated functions, crucial in the immune response, particularly in the context of pathogen recognition and antigen processing.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

FCM Lysing solution (1x)

sc-3621
150 ml
$62.00
8
(1)

Ammonium Chloride, used to increase endosomal pH, could indirectly enhance DC-SIGN/CD209a activity by impacting receptor-mediated endocytosis and antigen processing.

2-Hydroxypropyl-β-cyclodextrin

128446-35-5sc-203461
sc-203461B
sc-203461C
sc-203461A
1 g
100 g
500 g
5 g
$53.00
$620.00
$1989.00
$133.00
8
(1)

Methyl-β-cyclodextrin, known for cholesterol depletion, can indirectly enhance DC-SIGN/CD209a activity by affecting membrane microdomain composition, potentially altering receptor function.

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$165.00
$486.00
64
(4)

Cytochalasin D, an actin polymerization inhibitor, can indirectly enhance DC-SIGN/CD209a activity by affecting cytoskeletal arrangements, impacting receptor-mediated endocytosis.

Filipin III

480-49-9sc-205323
sc-205323A
500 µg
1 mg
$118.00
$148.00
26
(2)

Filipin III, a cholesterol-binding compound, may indirectly modulate DC-SIGN/CD209a activity by disrupting lipid rafts, affecting receptor localization and function.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$89.00
44
(2)

Dynasore, a dynamin inhibitor, could indirectly enhance DC-SIGN/CD209a activity by altering endocytic trafficking, potentially impacting antigen processing and presentation.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin, a PI3K inhibitor, may indirectly affect DC-SIGN/CD209a activity by altering signaling pathways involved in dendritic cell maturation and antigen presentation.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Genistein, a tyrosine kinase inhibitor, can indirectly enhance DC-SIGN/CD209a activity by modulating cellular signaling pathways, potentially affecting receptor-mediated functions.

Nystatin

1400-61-9sc-212431
sc-212431A
sc-212431B
sc-212431C
5 MU
25 MU
250 MU
5000 MU
$51.00
$129.00
$251.00
$3570.00
7
(1)

Nystatin, an antifungal medication, may indirectly impact DC-SIGN/CD209a activity by altering membrane cholesterol content, affecting receptor distribution and function.

Colchicine

64-86-8sc-203005
sc-203005A
sc-203005B
sc-203005C
sc-203005D
sc-203005E
1 g
5 g
50 g
100 g
500 g
1 kg
$100.00
$321.00
$2289.00
$4484.00
$18207.00
$34749.00
3
(2)

Colchicine, an anti-inflammatory compound, could indirectly enhance DC-SIGN/CD209a activity by affecting microtubule dynamics, potentially influencing antigen uptake and processing.